Answers are grounded in this paper and cite their sources.
Interview with Prof. Kevin Outterson on the recent fungal meningitis outbreak and the regulation of compounding pharmacies in the United States. (12:22)Download FDA rules are often forged in crisis. Compounding pharmacies are at the center of a controversy after an outbreak of fungal meningitis that was traced to methylprednisolone acetate from the New England Compounding Center. Congress is already discussing new regulations.
No takes yet. Share an insight, caveat, or question.
Kevin Outterson (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: